Mikhail A Godkov
Overview
Explore the profile of Mikhail A Godkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Potemkin I, Kyuregyan K, Karlsen A, Isaeva O, Kichatova V, Lopatukhina M, et al.
Viruses
. 2024 Apr;
16(4).
PMID: 38675869
Transfusion-transmitted hepatitis E virus (HEV) infection is an increasing concern in many countries. We investigated the detection rate of HEV viremia in blood donors in Russia. A total of 20,405...
2.
Godkov M, Ogarkova D, Gushchin V, Kleymenov D, Mazunina E, Bykonia E, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679936
Vaccination against COVID-19 has occurred in Russia for more than two years. According to the Russian official clinical guidelines to maintain tense immunity in the conditions of the ongoing COVID-19...
3.
Minashkin M, Grigortsevich N, Kamaeva A, Barzanova V, Traspov A, Godkov M, et al.
Biomedicines
. 2022 Mar;
10(3).
PMID: 35327350
The aim of this study was to identify single nucleotide variants in genes associated with susceptibility to or severe outcomes of COVID-19. A total of 319 genomic DNA samples from...
4.
Kichatova V, Asadi Mobarkhan F, Potemkin I, Zlobin S, Perfilieva O, Valuev-Elliston V, et al.
Microorganisms
. 2022 Feb;
10(2).
PMID: 35208883
Anti-SARS-CoV-2 antibody testing is an efficient tool to assess the proportion of seropositive population due to infection and/or vaccination. Numerous test systems utilizing various antigen composition(s) are routinely used for...
5.
Impact of pathogen reduction methods on immunological properties of the COVID-19 convalescent plasma
Kostin A, Lundgren M, Bulanov A, Ladygina E, Chirkova K, Gintsburg A, et al.
Vox Sang
. 2021 Mar;
116(6):665-672.
PMID: 33734455
Background And Objectives: COVID-19 convalescent plasma is an experimental treatment against SARS-CoV-2. The aim of this study is to assess the impact of different pathogen reduction methods on the levels...